{"id":980633,"date":"2026-07-10T08:33:49","date_gmt":"2026-07-10T12:33:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/"},"modified":"2026-07-10T08:33:49","modified_gmt":"2026-07-10T12:33:49","slug":"agilon-health-reports-aco-reach-model-results-for-2024-performance-year","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/","title":{"rendered":"agilon health Reports ACO REACH Model Results for 2024 Performance Year"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>agilon health Reports ACO REACH Model Results for 2024 Performance Year<\/b><\/p>\n<p class=\"bwalignc\"><b><i>In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score<\/i><\/b><\/p>\n<p class=\"bwalignc\"><b><i>Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including <\/i><i>$125 million in savings to Medicare Trust Fund<\/i><\/b><\/p>\n<p>WESTERVILLE, Ohio&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nagilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon\u2019s eight REACH ACOs operate under full risk, and in 2024 were responsible for the total cost and quality of care for approximately 121,000 Traditional Medicare beneficiaries.<\/p>\n<p>\n\u201cagilon health is redefining what\u2019s possible in senior care. By helping physicians embrace full-risk models, we\u2019re transforming the shift to value into real-world impact \u2014 better outcomes, lower costs and greater access,\u201d said Dr. Karthik Rao, chief medical officer at agilon health. \u201cAs ACO REACH is currently the only full-risk program within Traditional Medicare, we remain deeply supportive of ACO REACH and its vital role in strengthening local primary care and empowering physicians to deliver truly holistic care for the seniors who depend on them.\u201d<\/p>\n<p>\nFor the 2024 performance year, the average quality score for agilon\u2019s eight REACH ACOs was 96%. In fact, four of these REACH ACOs attained a 100% quality score. In addition, five attained High Performers Pool status, achieving superior quality results across all four quality measures.<\/p>\n<p>\n\u201cOur long-standing partnership with agilon health has truly transformed the way we care for our patients,\u201d said Dr. John Notaro from the Buffalo Medical Group, a participating physician in the ACO REACH program. \u201cBy embracing full-risk models, we\u2019ve been able to focus more on preventive, personalized care for our seniors. The savings generated through ACO REACH have allowed us to reinvest directly into our practice \u2014 expanding care teams, enhancing technology and developing clinical care programs that are making a real difference in the experience and health of the patients and families we serve.\u201d<\/p>\n<p>\nIn 2024, agilon\u2019s REACH ACOs included 1,500 primary care physicians (PCPs) operating across 13 communities in Hawaii, New York, North Carolina, Ohio, Pennsylvania and Texas. Since joining the ACO REACH model in 2021, agilon\u2019s REACH ACOs have achieved $510 million in gross savings, including $125 million in total savings to the Medicare Trust Fund. Of note, agilon also had five ACOs among the top 20 Standard ACOs in gross savings rate.<\/p>\n<p><b>About the ACO REACH model<\/b><\/p>\n<p>\nThe ACO Realizing Equity, Access and Community Health (REACH) model encourages health care providers \u2014 including primary and specialty care doctors, hospitals and others \u2014 to come together to form an Accountable Care Organization, or ACO. ACOs break down silos and deliver high-quality, coordinated care to their patients, improve health outcomes and manage costs. For questions about the ACO REACH model, call 1-800-MEDICARE (1-800-633-4227), TTY 877-486-2048. For questions about agilon\u2019s Senior Health Connect ACOs, call 866-407-1660.<\/p>\n<p><b>About agilon health<\/b><\/p>\n<p>\nagilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups and health systems transition to a value-based Total Care Model for their senior patients. agilon provides the technology, people, capital, process and access to a peer network of approximately 2,300 primary care physicians (PCPs) that allow its physician partners to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need \u2013 one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in approximately 30 communities and is here to help more of our nation&#8217;s leading physician groups and health systems have a sustained, thriving future. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.agilonhealth.com%2F&amp;esheet=54568329&amp;newsitemid=20260710982829&amp;lan=en-US&amp;anchor=agilonhealth.com&amp;index=1&amp;md5=080ef6156c88d79c0284929e3e1f01c6\">agilonhealth.com<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fagilonhealth&amp;esheet=54568329&amp;newsitemid=20260710982829&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=8de2f7f8202e29285743aade34777b62\">LinkedIn<\/a>.<\/p>\n<p><i>The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.<\/i><\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nStatements in this release that are not historical factual statements are \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among other things, statements regarding our and our officers\u2019 intent, belief or expectation as identified by the use of words such as \u201cgoals,\u201d \u201cbelieves,\u201d \u201cexpects,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cshall,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cseeks,\u201d \u201caims,\u201d \u201cprojects,\u201d \u201cis optimistic,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cestimates,\u201d \u201canticipates\u201d or the negative versions of these words or other comparable terms. Examples of forward-looking statements include, among other things: statements about transforming health care, redefining what&#8217;s possible in senior care, accelerating transitions to value-based care models, our role in creating healthcare systems, anticipated shared savings or shared losses, and our expected performance under ACO benchmarks. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could significantly affect our ability to accomplish our goals, future financial condition, and results of operations. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be outside our control. These risks and uncertainties that could cause actual results and outcomes to differ from those reflected in forward looking statements include, but are not limited to: our history of net losses and the expectation that our expenses will increase in the future; failure to identify and develop successful new geographies, physician partners and payors, or execute upon our growth initiatives; success in executing our operating strategies or achieving results consistent with our historical performance; medical expenses incurred on behalf of our members may exceed revenues we receive; our ability to maintain and secure additional contracts with Medicare Advantage payors on favorable terms, if at all; our ability to grow new physician partner relationships sufficient to recover startup costs; availability of additional capital, on acceptable terms or at all, to support our business in the future; significant reduction in our membership; transition to a Total Care Model may be challenging for physician partners; public health crises, such as pandemics or epidemics, could adversely affect us; inaccuracy in estimates of our members\u2019 risk adjustment factors, medical services expense, incurred but not reported claims, and earnings pursuant to payor contracts; the impact of restrictive clauses or exclusivity provisions in some of our contracts with physician partners; our ability to hire and retain qualified personnel; our ability to realize the full value of our intangible assets; security breaches, cybersecurity attacks, loss of data and other disruptions to our information systems; our ability to protect the confidentiality of our know-how and other proprietary and internally developed information; reliance on our subsidiaries to perform and fund their operations; reliance on a limited number of key payors; our use of algorithms, artificial intelligence and machine learning; the limited terms of contracts with our payors and our ability to renew them upon expiration; our ability to navigate the changing healthcare payor market; reliance on our payors, physician partners and other providers to operate our business; our ability to obtain accurate and complete diagnosis data; reliance on third-party software, data, infrastructure and bandwidth; consolidation and competition in the healthcare industry; our participation in and dependence on government healthcare programs, including the ACO REACH model; changes to government healthcare programs, including modifications or termination of the ACO REACH model; uncertain or adverse economic and macroeconomic conditions, including a downturn or decrease in government expenditures; regulation of the healthcare industry and our and our physician partners\u2019 ability to comply with such laws and regulations; federal and state investigations, audits and enforcement actions; repayment obligations arising out of payor audits; negative publicity regarding the managed healthcare industry generally; our use, disclosure and processing of personally identifiable information, protected health information, and de-identified data; failure to obtain or maintain an insurance license, a certificate of authority or an equivalent authorization; non-compliance with the New York Stock Exchange; lawsuits not covered by insurance and securities class action litigation; changes in tax laws and regulations, or changes in related judgments or assumptions; our indebtedness and our potential to incur more debt; dependence on our subsidiaries for cash to fund all of our operations and expenses; provisions in our governing documents; the ability of stockholders to achieve a return on their investment depends on appreciation in the price of our common stock; sustainability issues; stock price volatility; our management transition and our ability to effectively manage leadership changes; and risks related to other factors discussed in our filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including the factors discussed under \u201cRisk Factors\u201d in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which can be found at the SEC\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54568329&amp;newsitemid=20260710982829&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=3&amp;md5=d2a4f200517873c23ea92fff2964ab8d\">www.sec.gov<\/a>. Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260710982829\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260710982829\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contacts<br \/>\n<\/b><br \/>Evan Smith, CFA<br \/>\n<br \/>SVP Investor Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:evan.smith@agilonhealth.com\">evan.smith@agilonhealth.com<br \/>\n<\/a><\/p>\n<p>Megan Cagle<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@agilonhealth.com\">investors@agilonhealth.com<br \/>\n<\/a><\/p>\n<p><b>Media Contact<br \/>\n<\/b><br \/>Stephanie Law<br \/>\n<br \/>Senior Director, Marketing &amp; Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@agilonhealth.com\">media@agilonhealth.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Ohio United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Managed Care General Health Health Practice Management<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260710982829\/en\/1220694\/3\/Agilon_Logo_640x360.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>agilon health Reports ACO REACH Model Results for 2024 Performance Year In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including $125 million in savings to Medicare Trust Fund WESTERVILLE, Ohio&#8211;(BUSINESS WIRE)&#8211; agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon\u2019s eight REACH ACOs operate under full &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;agilon health Reports ACO REACH Model Results for 2024 Performance Year&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-980633","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>agilon health Reports ACO REACH Model Results for 2024 Performance Year - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"agilon health Reports ACO REACH Model Results for 2024 Performance Year - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"agilon health Reports ACO REACH Model Results for 2024 Performance Year In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including $125 million in savings to Medicare Trust Fund WESTERVILLE, Ohio&#8211;(BUSINESS WIRE)&#8211; agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon\u2019s eight REACH ACOs operate under full &hellip; Continue reading &quot;agilon health Reports ACO REACH Model Results for 2024 Performance Year&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-10T12:33:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"agilon health Reports ACO REACH Model Results for 2024 Performance Year\",\"datePublished\":\"2026-07-10T12:33:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/\"},\"wordCount\":1626,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/\",\"name\":\"agilon health Reports ACO REACH Model Results for 2024 Performance Year - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-07-10T12:33:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"agilon health Reports ACO REACH Model Results for 2024 Performance Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"agilon health Reports ACO REACH Model Results for 2024 Performance Year - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/","og_locale":"en_US","og_type":"article","og_title":"agilon health Reports ACO REACH Model Results for 2024 Performance Year - Market Newsdesk","og_description":"agilon health Reports ACO REACH Model Results for 2024 Performance Year In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including $125 million in savings to Medicare Trust Fund WESTERVILLE, Ohio&#8211;(BUSINESS WIRE)&#8211; agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon\u2019s eight REACH ACOs operate under full &hellip; Continue reading \"agilon health Reports ACO REACH Model Results for 2024 Performance Year\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-10T12:33:49+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"agilon health Reports ACO REACH Model Results for 2024 Performance Year","datePublished":"2026-07-10T12:33:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/"},"wordCount":1626,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/","name":"agilon health Reports ACO REACH Model Results for 2024 Performance Year - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-07-10T12:33:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260710982829r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilon-health-reports-aco-reach-model-results-for-2024-performance-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"agilon health Reports ACO REACH Model Results for 2024 Performance Year"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=980633"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980633\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=980633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=980633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=980633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}